These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10718119)

  • 21. Antagonism by fenamates of prostaglandin action in guinea-pig and human alimentary muscle.
    Bennett A; Pratt D; Sanger GJ
    Br J Pharmacol; 1980 Mar; 68(3):357-62. PubMed ID: 7052332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina.
    Chen Q; Olney JW; Lukasiewicz PD; Almli T; Romano C
    Neurosci Lett; 1998 Feb; 242(3):163-6. PubMed ID: 9530931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of hepatic and duodenal sulfation of (-)-salbutamol and minoxidil by mefenamic acid.
    Vietri M; Pietrabissa A; Spisni R; Mosca F; Pacifici GM
    Eur J Clin Pharmacol; 2000 Sep; 56(6-7):477-9. PubMed ID: 11049010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids.
    Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 1988; 35(5):495-501. PubMed ID: 3266151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form.
    Campbell NR; Van Loon JA; Weinshilboum RM
    Biochem Pharmacol; 1987 May; 36(9):1435-46. PubMed ID: 3472524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High level expression and characterization of recombinant human hippocampus phenol sulfotransferase: a novel phenol-sulfating form of phenol sulfotransferase.
    Hwang SR; Palkovits M; Hook VY
    Protein Expr Purif; 1997 Oct; 11(1):125-34. PubMed ID: 9325148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenamates potentiate the alpha 1-adrenoceptor-activated nonselective cation channels in rabbit portal vein smooth muscle.
    Yamada K; Waniishi Y; Inoue R; Ito Y
    Jpn J Pharmacol; 1996 Jan; 70(1):81-4. PubMed ID: 8822092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form.
    Sundaram RS; Szumlanski C; Otterness D; van Loon JA; Weinshilboum RM
    Drug Metab Dispos; 1989; 17(3):255-64. PubMed ID: 2568905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical properties of anti-inflammatory drugs. XI. Structure-action relationship for the uncoupling of oxidative phosphorylation and inhibition of chymotrypsin by N-substituted anthranilates and related compounds.
    Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):753-60. PubMed ID: 6036726
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.
    Ottolia M; Toro L
    Biophys J; 1994 Dec; 67(6):2272-9. PubMed ID: 7535111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate inhibitor of phenolsulfotransferase.
    Seah VM; Wong KP
    Biochem Pharmacol; 1994 May; 47(10):1743-9. PubMed ID: 8204091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenamates inhibit contraction of guinea-pig isolated bronchus in vitro independent of prostanoid synthesis inhibition.
    Li L; Vapaatalo H; Vaali K; Paakkari I; Kankaanranta H
    Life Sci; 1998; 62(19):PL289-94. PubMed ID: 9585115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature.
    Pacifici GM
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):488-95. PubMed ID: 15487807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'-triphosphate.
    Collier HO; James GW; Schneider C
    Nature; 1966 Oct; 212(5060):411-2. PubMed ID: 4381910
    [No Abstract]   [Full Text] [Related]  

  • 36. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention.
    Eaton EA; Walle UK; Lewis AJ; Hudson T; Wilson AA; Walle T
    Drug Metab Dispos; 1996 Feb; 24(2):232-7. PubMed ID: 8742236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationship of fenamates as Slo2.1 channel activators.
    Garg P; Sanguinetti MC
    Mol Pharmacol; 2012 Nov; 82(5):795-802. PubMed ID: 22851714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological control of human polymorphonuclear leukocyte degranulation by fenamates and inhibitors of receptor-mediated calcium entry and protein kinase C.
    Kankaanranta H; Moilanen E; Lindberg K; Vapaatalo H
    Biochem Pharmacol; 1995 Jul; 50(2):197-203. PubMed ID: 7632163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa.
    Cappiello M; Giuliani L; Pacifici GM
    Pharmacology; 1990; 40(2):69-76. PubMed ID: 2345774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate.
    Wang LQ; Lehmler HJ; Robertson LW; James MO
    Chem Biol Interact; 2006 Feb; 159(3):235-46. PubMed ID: 16413005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.